Comprehensive geriatric assessment and traditional Chinese medicine intervention benefit symptom control in elderly patients with advanced non-small cell lung cancer

Medical Oncology

Volumn 32, Issue 4, 2015, Pages 1-7

  Xue, Dong ^a   Han, Shuyan ^a   Jiang, Shantong ^a   Sun, Hong ^a   Chen, Yanzhi ^a   Li, Yuanqing ^a   Wang, Wei ^a   Feng, Ye ^a   Wang, Ke ^a   Li, Pingping ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Advanced lung cancer; Clinical benefit; Comprehensive geriatric assessment; Elderly patient; Quality of life; Symptom control

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; GEMCITABINE; NAVELBINE; PACLITAXEL; PEMETREXED; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CHINESE MEDICINE; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; COUGHING; DYSPHORIA; DYSPNEA; FATIGUE; FEMALE; FUNCTIONAL STATUS; FUNCTIONAL STATUS ASSESSMENT; GERIATRIC ASSESSMENT; GERIATRIC PATIENT; HUMAN; INSOMNIA; LOSS OF APPETITE; MALE; MULTIPLE CYCLE TREATMENT; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SURVIVAL TIME; SWEATING; WESTERN MEDICINE; ADENOCARCINOMA; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FOLLOW UP; LUNG NEOPLASMS; PATHOLOGY; PROGNOSIS; QUALITY OF LIFE; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FATIGUE; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HUMANS; LUNG NEOPLASMS; MALE; MEDICINE, CHINESE TRADITIONAL; NEOPLASM STAGING; PROGNOSIS; QUALITY OF LIFE;

EID: 84924968900     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-015-0563-5     Document Type: Article

References (19)

1. Caillet P, Canoui-Poitrine F, Vouriot J, Berle M, Reinald N, Krypciak S, et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer. ELCAPA study. J Clin Oncol. 2011;29:3636–42.
2. Chen CC, Kenefick AL, Tang ST, McCorkle R. Utilization of comprehensive geriatric assessment in cancer patients. Crit Rev Oncol Hematol. 2004;49:53–67.
3. Kristjansson SR, Nesbakken A, Jordhøy MS, Skovlund E, Audisio RA, Johannessen HO, et al. Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study. Crit Rev Oncol Hematol. 2010;76:208–17.
4. Extermann M, Aapro M, Bernabei R, Cohen HJ, Droz JP, Lichtman S, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005;55:241–52.
5. Kim KI, Park KH, Koo KH, Han HS, Kim CH. Comprehensive geriatric assessment can predict postoperative morbidity and mortality in elderly patients undergoing elective surgery. Arch Gerontol Geriatr. 2013;56:507–12.
6. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.
7. Lin G, Li Y, Chen S, Jiang H. Integrated Chinese-western therapy versus western therapy alone on survival rate in patients with non-small-cell lung cancer at middle-late stage. J Tradit Chin Med. 2013;33:433–8.
8. You J, Shan MJ, Zhao H. Clinical study of integrative treatment for ninety-one elderly patients with advanced non-small cell lung cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi (Chin). 2012;32:774–8.
9. Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L, et al. Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res. 2013;25:10–21.
10. VanderWalde A, Pal SK, Reckamp KL. Management of non-small-cell lung cancer in the older adult. Maturitas. 2011;68:311–21.
11. Hurria A, Kris MG. Management of lung cancer in older adults. CA Cancer J Clin. 2003;53:325–41.
12. Tas F, Ciftci R, Kilic L, Karabulut S. Age is a prognostic factor affecting survival in lung cancer patients. Oncol Lett. 2013;6:1507–13.
13. Pal SK, Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol. 2010;28:4086–93.
14. Kanesvaran R, Li H, Koo KN, Poon D. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol. 2011;29:3620–7.
15. Chaïbi P, Magné N, Breton S, Chebib A, Watson S, Duron JJ, et al. Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. Crit Rev Oncol Hematol. 2011;79:302–7.
16. Rao AV, Hsieh F, Feussner JR, Cohen HJ. Geriatric evaluation and management units in the care of the frail elderly cancer patient. J Gerontol A Biol Sci Med Sci. 2005;60:798–803.
17. Extermann M, Chen H, Cantor AB, Corcoran MB, Meyer J, Grendys E, et al. Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer. 2002;38:1466–73.
18. Parks RM, Lakshmanan R, Winterbottom L, Al Morgan D, Cox K, Cheung KL. Comprehensive geriatric assessment for older women with early breast cancer—a systematic review of literature. World J Surg Oncol. 2012;10:88.
19. Ruiz M, Reske T, Cefalu C, Estrada J. Management of elderly and frail elderly cancer patients: the importance of comprehensive geriatrics assessment and the need for guidelines. Am J Med Sci. 2013;346:66–9.